Price $6.96 |
Market Cap
503.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.61
|
P/S
8.81
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-22.5K
|
FCF
-0.3
|
|
Op. Margin
-47.40%
|
Net Margin
-53.40%
|
ROE
-9.40%
|
ROI
16.20%
|
|
ROA
-8.60%
|
EPS Growth
-214.60%
|
Current Ratio
16.7
|
Debt/Equity
0.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Acura Pharmaceuticals, Inc. (ACUR) | $0.29 | - | - | 6.2M | Strong Buy |
| Daxor Corporation (DXR) | $16.64 | - | - | 69.3M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.62 | - | - | 122M | Strong Buy |
| Resonate Blends Inc (KOAN) | $0.14 | - | - | 4.4M | Strong Buy |
| Endo International PLC (ENDP) | $3.12 | - | - | 785.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
